Joshua M Eizen
Chief Operating Officer and Chief Legal Officer · 3 filings · Latest: Jul 8, 2026
AN2 Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ANTX | Joshua M Eizen | Chief Operating Officer and Chief Legal Officer | Jul 8, 2026 | Sale | $4.17 | 5,945 | $24.8K | 206,554 |